DEERFIELD MANAGEMENT COMPANY, L.P.
Q2 2025 13F Holdings
- Locationnew york, NY
- Num holdings
124
- Value ($000)
$5,509,809
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001009258
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NUVL NUVALENT INC | COM | 670703107 | $1.37 B | 25 % | 17,991,024 | ||
OSCR OSCAR HEALTH INC | CL A | 687793109 | $249.77 M | 5 % | 11,649,591 | ||
VTRS VIATRIS INC | COM | 92556V106 | $214.53 M | 4 % | 24,023,907 | ||
MERUS N V | COM | N5749R100 | $178.03 M | 3 % | 3,384,628 | ||
CNC CENTENE CORP DEL | COM | 15135B101 | $172.90 M | 3 % | 3,185,370 | ||
IART 0.5 08/15/25 INTEGRA LIFESCIENCES HLDGS C | NOTE 0.500% 8/1 | 457985AM1 | $172.86 M | 3 % | 174,364,000 | ||
ARS PHARMACEUTICALS INC | COM | 82835W108 | $169.69 M | 3 % | 9,724,508 | ||
INDIVIOR PLC | ORD | G4766E116 | $155.76 M | 3 % | 10,567,160 | ||
UTH UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | $155.35 M | 3 % | 540,626 | ||
NBIX NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | $146.78 M | 3 % | 1,167,802 |
Rows Per Page
10
- 10
- 50
- 100